Farther Finance Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.02M Buy
11,100
+4,165
+60% +$1.08M 0.02% 602
2026
Q2
$1.72M Buy
6,935
+75
+1% +$16.2K 0.01% 816
2026
Q1
$1.39M Buy
6,860
+1,249
+22% +$258K 0.01% 809
2025
Q4
$1.16M Sell
5,611
-252
-4% -$50.4K 0.01% 811
2025
Q3
$1.05M Sell
5,863
-93
-2% -$15.8K 0.02% 698
2025
Q2
$961K Buy
5,956
+48
+0.8% +$7.65K 0.02% 606
2025
Q1
$972K Buy
5,908
+5,808
+5,808% +$1.01M 0.02% 517
2024
Q4
$16.6K Hold
100
– – ﹤0.01% 2164
2024
Q3
$17.2K Buy
100
+50
+100% +$8.28K ﹤0.01% 2150
2024
Q2
$7.68K Hold
50
– – ﹤0.01% 2185
2024
Q1
$7.7K Hold
50
– – ﹤0.01% 1868
2023
Q4
$7.9K Hold
50
– – ﹤0.01% 1726
2023
Q3
$7.32K Hold
50
– – ﹤0.01% 1392
2023
Q2
$7.66K Hold
50
– – ﹤0.01% 1279
2023
Q1
$7.75K Hold
50
– – ﹤0.01% 1204
2022
Q4
$7.71K Buy
+50
New +$7.38K ﹤0.01% 1037

Other funds holding FBT

Farther Finance Advisors's FBT Position: Q3 2026 in Review

Farther Finance Advisors increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 60% in Q3 2026, buying an estimated $1.08M and bringing the position to 11,100 shares worth $3.02M. The position accounts for 0.02% of the portfolio, ranked #602.

Farther Finance Advisors first reported a position in FBT in Q4 2022 and has held it in 16 quarters since. 22 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Farther Finance Advisors held 11,100 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.02M as of Q3 2026.
  • Farther Finance Advisors bought 4,165 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $1.08M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Farther Finance Advisors's portfolio in Q3 2026, its #602 holding.
  • Farther Finance Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 16 quarters since.
  • 22 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.